These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21717897)

  • 21. Here's the plan. AHA offers Medicare changes to federal commission.
    Weissenstein E
    Mod Healthc; 1998 Nov; 28(47):2. PubMed ID: 10187690
    [No Abstract]   [Full Text] [Related]  

  • 22. Ganging up on the FDA.
    Stone PH
    Natl J (Wash); 1995 Feb; 27(7):410-4. PubMed ID: 10140321
    [No Abstract]   [Full Text] [Related]  

  • 23. Leukemia Society of America testifies on FDA reform.
    Rudnick S
    Oncology (Williston Park); 1996 Aug; 10(8):1139. PubMed ID: 8869956
    [No Abstract]   [Full Text] [Related]  

  • 24. Healthcare reimbursement for oncology care.
    Bence S
    Pa Nurse; 2006 Jun; 61(2):17, 29. PubMed ID: 16871983
    [No Abstract]   [Full Text] [Related]  

  • 25. Who would approve new drugs if there were no FDA?
    Gatty B
    Hosp Formul; 1995 Jan; 30(1):58, 57. PubMed ID: 10139726
    [No Abstract]   [Full Text] [Related]  

  • 26. Finally on track: Quality of care.
    van Rijswijk L
    Ostomy Wound Manage; 2007 Jan; 53(1):12, 14. PubMed ID: 17328155
    [No Abstract]   [Full Text] [Related]  

  • 27. Administration tips hand on new CLIA changes.
    Albertson D
    MLO Med Lab Obs; 1994 Feb; 26(2):16-7, 19. PubMed ID: 10131763
    [No Abstract]   [Full Text] [Related]  

  • 28. Blueprint for Medicare: the march toward a value-based payment program.
    Ferman JH
    Healthc Exec; 2007; 22(3):58, 60. PubMed ID: 17523352
    [No Abstract]   [Full Text] [Related]  

  • 29. Healthcare 'reform': deep cuts likely for Medicare providers.
    Gatty B
    Geriatrics; 1994 Sep; 49(9):54-6. PubMed ID: 8088560
    [No Abstract]   [Full Text] [Related]  

  • 30. The Accountable Care Organization (ACO) model: building blocks for success.
    Lowell KH; Bertko J
    J Ambul Care Manage; 2010; 33(1):81-8. PubMed ID: 20027005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healthcare reform: it's time.
    Gershenson DM
    Gynecol Oncol; 2009 Nov; 115(2):181. PubMed ID: 19709721
    [No Abstract]   [Full Text] [Related]  

  • 32. The FDA and "privatization"--the drug approval process.
    Rutherford EM
    Food Drug Law J; 1995; 50 Spec():203-25. PubMed ID: 10343044
    [No Abstract]   [Full Text] [Related]  

  • 33. Stakeholders say FDA must change REMS program.
    Reinke T
    Manag Care; 2011 Mar; 20(3):8-9. PubMed ID: 21485624
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Members' outcry heard by Medicare regulators.
    Pa Med; 1995 Oct; 98(10):18. PubMed ID: 8524593
    [No Abstract]   [Full Text] [Related]  

  • 36. Erythropoietin, the FDA, and oncology.
    Steinbrook R
    N Engl J Med; 2007 Jun; 356(24):2448-51. PubMed ID: 17568025
    [No Abstract]   [Full Text] [Related]  

  • 37. Medicare: will it last?
    Petasnich WD
    J Healthc Manag; 2011; 56(4):229-33. PubMed ID: 21838021
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA rulemaking after the 104th Congress: major rules enter the twilight zone of review.
    O'Reilly JT
    Food Drug Law J; 1996; 51(4):677-95. PubMed ID: 11797735
    [No Abstract]   [Full Text] [Related]  

  • 39. The party's over. Amid Medicare birthday, talk on quality gets serious.
    Fong T
    Mod Healthc; 2005 Aug; 35(31):10-1. PubMed ID: 16114830
    [No Abstract]   [Full Text] [Related]  

  • 40. Consider medicare drug benefit plan for healthcare reform.
    Henschke MR
    J Am Osteopath Assoc; 2002 Oct; 102(10):523-4. PubMed ID: 12401037
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.